ENDPOINTS NEWS13m
‘Too el­e­gant to ig­nore’: No­vo-al­lied As­pect Biosys­tems nabs $115M for bio­print­ed tis­sue ther­a­pies
Aspect Biosystems raises $115M Series B for bioprinted tissue therapeutics targeting diabetes and metabolic disorders, led by ...
ENDPOINTS NEWS28m
Vir’s ear­ly T cell en­gager da­ta of­fer first look at can­cer piv­ot
Vir Biotechnology reports early data on T cell engagers VIR-5818 and VIR-5500, licensed from Sanofi, showing tumor shrinkage ...
ENDPOINTS NEWS51m
Gala­pa­gos to split in­to two com­pa­nies, slash head­count as it eyes turn­around
Galapagos is looking for a fresh start after a rough few years. The Belgian biotech has outlined plans to branch off into two ...